Search

everythinglearnresearchcommunity

for

Search:↓

In 1995, international medical graduates did better than U.S. graduates on a medical exam.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

A teenage girl's excessive hair growth was caused by a medication for mania, but improved after stopping the medication.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

More research is needed to understand how testosterone is maintained in adult males.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

People with male pattern baldness are more likely to have metabolic syndrome.

Balding men, especially young ones, may have higher risk of heart issues and diabetes; check cholesterol levels.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Female hair loss linked to metabolic syndrome, not in males.

People with androgenetic alopecia have a higher risk of metabolic syndrome.

Hair loss links to high blood pressure, high fat levels, and metabolic issues, suggesting early heart disease screening.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Korean patients with androgenetic alopecia may have a higher risk of heart-related health issues and could benefit from early heart screening and healthier lifestyles.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Thujae occidentalis semen extract may help treat male pattern baldness by blocking a hair loss-related enzyme and reducing hair loss in mice.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Niacin derivatives may increase hair fullness in women with hair loss.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.